Results of studies on the effect of chromium supplementation on blood pressure (BP) are contradictory. The purpose of the current study was to carry out a meta-analysis on the effects of chromium supplementation on systolic blood pressure (SBP) and diastolic blood pressure (DBP). We conducted a systematic literature search of PubMed, SCOPUS, Cochrane Library, Web of Science, and Embase databases from inception up to July 2020 for randomized controlled trials (RCTs) that evaluate the impacts of chromium on SBP and DBP. A random-effects model was used to compute weighted mean differences (WMDs) with 95% confidence intervals (CIs). Heterogeneity was determined by I2 statistics and the Cochrane Q test. Sensitivity analysis was performed by eliminating each study one by one and recalculating the pooled effect. Ten studies comprising a total of 624 subjects were included in our meta-analysis. Chromium supplementation did not significantly change SBP (WMD: −0.642: 95% CI: (−2.15, 1.30) mmHg; p = 0.312; I2 = 12.7%) and DBP (WMD: −0.10; 95% CI: (−1.39, 1.18) mmHg; p = 0.070; I2 = 37.6%). Subgroup analysis based on dose and duration of chromium supplementation also did not significantly change the mean of SBP and DBP. The present meta-analysis of RCTs did not show the beneficial effects of chromium supplementation on BP in adults.
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Kumar J. Epidemiology of hypertension. Clin Queries: Nephrol. 2013;2:56–61.
Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285–92.
Matsumoto K, Jin Z, Homma S, Elkind MS, Rundek T, Mannina C, et al. Association between central blood pressure and subclinical cerebrovascular disease in older adults. Hypertension. 2020;75:580–7.
Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension. 2003;41:1341–5.
Castro I, Waclawovsky G, Marcadenti A. Nutrition and physical activity on hypertension: implication of current evidence and guidelines. Curr Hypertens Rev. 2015;11:91–9.
Askarpour M, Ghaedi E, Roshanravan N, Hadi A, Mohammadi H, Symonds ME, et al. Policosanol supplementation significantly improves blood pressure among adults: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2019.
Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med. 2006;144:485–95.
Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112–7.
Avila-Palencia I, Laeremans M, Hoffmann B, Anaya-Boig E, Carrasco-Turigas G, Cole-Hunter T, et al. Effects of physical activity and air pollution on blood pressure. Environ Res. 2019;173:387–96.
Cooper JA, Anderson BF, Buckley PD, Blackwell LF. Structure and biological activity of nitrogen and oxygen coordinated nicotinic acid complexes of chromium. Inorg Chim Acta. 1984;91:1–9.
Preuss H, Grojec P, Lieberman S, Anderson R. Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol. 1997;47:325–30.
EFSA Panel on Dietetic Products N, Allergies. Scientific opinion on dietary reference values for chromium. EFSA J 2014;12:3845.
Tao Y, editor. Progress in chromium research and related diseases. AIP Conference Proceedings; 2019. AIP Publishing LLC.
Preuss HG, Echard B, Perricone NV, Bagchi D, Yasmin T, Stohs SJ. Comparing metabolic effects of six different commercial trivalent chromium compounds. J Inorg Biochem. 2008;102:1986–90.
Sharma S, Agrawal RP, Choudhary M, Jain S, Goyal S, Agarwal V. Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J Trace Elem Med Biol. 2011;25:149–53.
Vrtovec M, Vrtovec B, Briski A, Kocijancic A, Anderson RA, Radovancevic B. Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus. Am Heart J. 2005;149:632–6.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9. w64
Higgins J, Green S. Assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions Version 5.1. 0; 2011. 2008.
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.
Chen Y-L, Lin J-D, Hsia T-L, Mao FC, Hsu C-H, Pei D. The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretion in type 2 diabetes. Eur J Nutr. 2014;53:127–33.
Kleefstra N, Houweling ST, Bakker SJ, Verhoeven S, Gans RO, Meyboom-de JB. Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2007;30:1092–6.
Ali A, Ma Y, Reynolds J, Wise J Sr, Inzucchi S, Katz D. Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus. Endocr Pract. 2011;17:16–25.
Farrokhian A, Mahmoodian M, Bahmani F, Amirani E, Shafabakhsh R, Asemi Z. The influences of chromium supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Biol Trace Elem Res. 2020;194:313–20.
Kleefstra N, Houweling ST, Jansman FG, Groenier KH, Gans RO, Meyboom-de Jong B, et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2006;29:521–5.
Nussbaumerova B, Rosolova H, Krizek M, Sefrna F, Racek J, Müller L, et al. Chromium supplementation reduces resting heart rate in patients with metabolic syndrome and impaired glucose tolerance. Biol Trace Elem Res. 2018;183:192–9.
Yazaki Y, Faridi Z, Ma Y, Ali A, Northrup V, Njike VY, et al. A pilot study of chromium picolinate for weight loss. J Alter Complement Med. 2010;16:291–9.
Imanparast F, Javaheri J, Kamankesh F, Rafiei F, Salehi A, Mollaaliakbari Z, et al. The effects of chromium and vitamin D3 co-supplementation on insulin resistance and tumor necrosis factor-alpha in type 2 diabetes: a randomized placebo-controlled trial. Appl Physiol Nutr Metab. 2020;45:471–7.
Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care. 2004;27:2741–51.
DesMarias TL, Costa M. Mechanisms of chromium-induced toxicity. Curr Opin Toxicol. 2019;14:1–7.
Asbaghi O, Fatemeh N, Mahnaz RK, Ehsan G, Elham E, Behzad N, et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 2020:105098.
Asbaghi O, Naeini F, Ashtary-Larky D, Moradi S, Zakeri N, Eslampour E, et al. Effects of chromium supplementation on lipid profile in patients with type 2 diabetes: a systematic review and dose-response meta-analysis of randomized controlled trials. J Trace Elem Med Biol. 2021:126741.
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17:1–14.
Choudhury KN, Mainuddin A, Wahiduzzaman M, Islam SMS. Serum lipid profile and its association with hypertension in Bangladesh. Vasc Health Risk Manag. 2014;10:327.
Ngala RA, Awe MA, Nsiah P. The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case-control study. PLoS ONE. 2018;13:e0197977.
Mozaffari MS, Baban B, Abdelsayed R, Liu JY, Wimborne H, Rodriguez N, et al. Renal and glycemic effects of high-dose chromium picolinate in db/db mice: assessment of DNA damage. J Nutr Biochem. 2012;23:977–85.
Anderson EA, Hoffman R, Balon T, Sinkey C, Mark A. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. Eur J Clin Investig. 1991;87:2246–52.
Perlstein TS, Gerhard-Herman M, Hollenberg NK, Williams GH, Thomas A. Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects. J Am Soc Nephrol. 2007;18:944–51.
Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta‐analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther. 2014;39:292–306.
Vincent JB. The biochemistry of chromium. J Nutr. 2000;130:715–8.
Lewicki S, Zdanowski R, Krzyzowska M, Lewicka A, Debski B, Niemcewicz M, et al. The role of Chromium III in the organism and its possible use in diabetes and obesity treatment. Ann Agric Environ Med. 2014;21:331–5.
Offenbacher EG, Pi-Sunyer FX. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 1980;29:919–25.
Sadeghi M, Najaf Panah MJ, Bakhtiarizadeh MR, Emami A. Transcription analysis of genes involved in lipid metabolism reveals the role of chromium in reducing body fat in animal models. J Trace Elem Med Biol. 2015;32:45–51.
Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, Webb DJ, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol. 2002;39:1005–11.
Kleefstra N, Houweling ST, Bilo HJ. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care. 2007;30:e102.
Institute of Medicine Panel on M. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington (DC): National Academies Press (US) Copyright 2001 by the National Academy of Sciences. All rights reserved. 2001.
Heimbach JT, Anderson RA. Chromium: recent studies regarding nutritional roles and safety. Nutr Today. 2005;40:189–95.
This research did not receive any specific grant. We would like to express our thanks to the Tehran University of Medical Sciences.
This research did not receive any specific grant from funding agencies in the public, commercial, or not 230 for-profit sectors.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ghanbari, M., Amini, M.R., Djafarian, K. et al. The effects of chromium supplementation on blood pressure: a systematic review and meta-analysis of randomized clinical trials. Eur J Clin Nutr (2021). https://doi.org/10.1038/s41430-021-00973-8